Browse 100 market data tables andÂ 52 figures spread through 193 pages and in-depth TOC on "Neurovascular Devices Market"
Early buyers will receive 10% customization on this report.
The key players in the neurovascular devices/interventional neurology market focused on various strategies such as product launches & enhancements; agreements and collaborations; strategic acquisitions; and expansions to increase market shares in the global market. Product launches & enhancements were the key strategies adopted by major industry players to achieve the desired market growth during 2013-2016.
This strategy was mainly adopted by Stryker Corporation (U.S.), Medtronic plc (U.S.), Johnson & Johnson (U.S.), Terumo Corporation (Japan), Penumbra, Inc. (U.S.), Abbott Laboratories (U.S.), Merit Medical Systems, Inc. (U.S.), W. L. Gore & Associates, Inc. (U.S.), and MicroPort Scientific Corporation (China). Apart from product launches & enhancements, many prominent players also adopted agreements & collaborations as the key growth strategy to strengthen market presence, enhance R&D capabilities, and to expand distribution networks to generate additional demand by sensitizing end users through an increase in availability of neurovascular products
Download the PDF Brochure@
Stryker Corporation (U.S.) held the leading position in the global market, in 2015. The company has a wide range of neurovascular products, including guidewires (such as Transend guidewires and Synchro guidewires), microcatheters (such as Excelsior SL-10 microcatheter and Excelsior 1018 microcatheter), balloon occlusion catheter (Transform occlusion balloon catheter), and detachable coils (such as Target XL detachable coils, Target Nano Detachable Coils, Target 360 Detachable Coils, and Target 3D Detachable Coils). The company has a strong presence in North America, Europe, the Middle East, Africa, Asia-Pacific and other countries.
The company has more than 30 manufacturing facilities in countries such as the U.S., China, Turkey, Germany, Ireland, Switzerland, and France. It primarily focuses on inorganic business growth strategies such as product development & commercialization, acquisitions, and market expansions. The company launched and commercialized clot retrieval device, namely, Trevo ProVue in November 2012 and acquired Synergetics USA, Inc. in April 2016, Trauson Holdings Company Limited (China) in March 2013, and Surpass Medical, Ltd. (Israel) in November 2012 to strengthen its R&D capabilities and expand its product portfolio in the global market.
Medtronic plc (Ireland) held the second position in the global market, in 2015. The company has a strong foothold in the market with a broad range of neurovascular products which include embolic coils, liquid embolics, microcatheters, guidewires, balloon catheters, clot retrieval devices, flow diversion devices, vascular embolization devices, remodeling devices, flow restoration devices, cranial repair products (such as TiMesh system and INVISx Cranial Fixation System), and shunts (such as StrataMR Adjustable Pressure Valve, Strata Adjustable Pressure Valve with Siphon Control and Strata NSC Adjustable Pressure Valve with No Siphon Control).
Get the Sample Pages@
To strengthen its current position and to gain a larger share in the market, the company aggressively focuses on inorganic growth strategies such as product development & commercialization, acquisitions, and market expansions.
During 2012-2016, the company developed and commercialized several neurovascular products such as Solitaire (TM) stent retriever device (November 2016), Pivox Oblique lateral spinal system with lateral plate for OLIF25 (July 2016), infuse bone graft (December 2015), and StealthStation electromagnetic (EM) surgical navigation system instruments (May 2015). In addition, the acquisition of Medina Medical (U.S.), Covidien plc (U.S.), Reverse Medical Corporation (U.S.), and Nfocus Neuromedical, Inc. (U.S.) enhanced its R&D capabilities and expanded its product portfolio in the global market.
MarketsandMarkets provides quantified B2B research on 30,000 high growth niche opportunities/threats which will impact 70% to 80% of worldwide companies' revenues. Currently servicing 7500 customers worldwide including 80% of global Fortune 1000 companies as clients. Almost 75,000 top officers across eight industries worldwide approach MarketsandMarkets for their painpoints around revenues decisions.
Our 850 fulltime analyst and SMEs at MarketsandMarketsâ„˘ are tracking global high growth markets following the "Growth Engagement Model - GEM". The GEM aims at proactive collaboration with the clients to identify new opportunities, identify most important customers, write "Attack, avoid and defend" strategies, identify sources of incremental revenues for both the company and its competitors. MarketsandMarketsâ„˘ now coming up with 1,500 MicroQuadrants (Positioning top players across leaders, emerging companies, innovators, strategic players) annually in high growth emerging segments. MarketsandMarkets is determined to benefit more than 10,000 companies this year for their revenue planning and help them take their innovations/disruptions early to the market by providing them research ahead of the curve.
MarketsandMarkets's flagship competitive intelligence and market research platform, "Knowledgestore" connects over 200,000 markets and entire value chains for deeper understanding of the unmet insights along with market sizing and forecasts of niche markets.
Mr. Shelly Singh
630 Dundee Road
Northbrook, IL 60062
USA : 1-888-600-6441
For more information, visit: https://www.marketsandmarkets.com/Market-Reports/neurointerventional-neurostimulation-devices-market-847.html